NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
12.68
-0.36 (-2.76%)
Mar 9, 2026, 2:03 PM EDT - Market open
NovoCure Employees
NovoCure had 1,605 employees as of December 31, 2025. The number of employees increased by 117 or 7.86% compared to the previous year.
Employees
1,605
Change (1Y)
117
Growth (1Y)
7.86%
Revenue / Employee
$408,320
Profits / Employee
-$84,877
Market Cap
1.44B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Enovis | 7,802 |
| QuidelOrtho | 6,500 |
| UFP Technologies | 4,846 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,500 |
| Artivion | 1,800 |
| Inspire Medical Systems | 1,333 |
NVCR News
- 7 days ago - Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer - Business Wire
- 9 days ago - Novocure to Participate in 2026 Leerink Global Healthcare Conference - Business Wire
- 11 days ago - NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - Business Wire
- 13 days ago - Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer) - Business Wire
- 24 days ago - NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching - Seeking Alpha
- 25 days ago - This Biotech Stock Is Jumping 25% After Getting an FDA Boost - Barrons
- 25 days ago - What's Happening With NovoCure Stock? - Forbes